PROPOSED RULES
Original Notice.
Preproposal statement of inquiry was filed as WSR 09-18-008.
Title of Rule and Other Identifying Information: Chapter 246-101 WAC, relating to reporting of communicable diseases and animal bites, excluding WAC 246-101-520 Special conditions -- AIDS and HIV and 246-101-635 Special conditions -- AIDS and HIV.
Hearing Location(s): State Board of Health Meeting, Shoreline Conference Center, 18560 1st Avenue N.E., Shoreline, WA 98155, on November 10, 2010, at 1:15 p.m.
Date of Intended Adoption: November 10, 2010.
Submit Written Comments to: Tracy Sandifer, Communicable Disease Epidemiology, Washington State Department of Health, 1610 N.E. 150th Street, Mailstop K17-9, Shoreline, WA 98155, web site http://www3.doh.wa.gov/policyreview/, fax (206) 418-5558, by November 4, 2010.
Assistance for Persons with Disabilities: Contact Tracy Sandifer by November 1, 2010, TTY (800) 833-6388 or 711.
Purpose of the Proposal and Its Anticipated Effects, Including Any Changes in Existing Rules: This rule revision proposal is intended to add newly identified conditions and remove no longer relevant conditions from the notification lists; clarify laboratory reporting requirements; incorporate references to new technologies; make laboratory, health care provider, and health care facilities notifiable conditions lists consistent; and clarify unclear language. The proposed rule revisions pertain only to reporting of communicable diseases.
Reasons Supporting Proposal: Since the rule was last revised on January 11, 2005, there have been a number of changes and developments in notifiable conditions reporting that should be addressed including: Identification of new conditions, national or international requirements, new laboratory methods, and improvements in reporting technologies. There is also a need to address current rule language that is unclear or incomplete. In addition, an emergency rule adopted on June 11, 2009, for the provisional reporting of novel influenza A (H1N1) for hospitalized patients or death needs to be reviewed for permanent notification.
Statutory Authority for Adoption: RCW 43.20.050.
Statute Being Implemented: RCW 43.20.050.
Rule is not necessitated by federal law, federal or state court decision.
Name of Proponent: State board of health, governmental.
Name of Agency Personnel Responsible for Drafting: Tracy Sandifer, DOH, 1610 N.E. 150th Street, Shoreline, (206) 418-5558 and Tara Wolff, SBOH, 101 Israel Road S.E., Tumwater, (360) 236-4101; Implementation and Enforcement: Judith May, 1610 N.E. 150th Street, Shoreline, WA, (206) 418-5500.
No small business economic impact statement has been prepared under chapter 19.85 RCW. The proposed rule would not impose more than minor costs on businesses in an industry.
A cost-benefit analysis is required under RCW 34.05.328. A preliminary cost-benefit analysis may be obtained by contacting Tracy Sandifer, Communicable Disease Epidemiology, Washington State Department of Health, 1610 N.E. 150th Street, Mailstop K17-9, Shoreline, WA 98155, phone (206) 418-5558, fax (206) 418-5515, e-mail tracy.sandifer@doh.wa.gov.
October 6, 2010
Craig McLaughlin
Executive Director
OTS-3653.2
AMENDATORY SECTION(Amending WSR 00-23-120, filed 11/22/00,
effective 12/23/00)
WAC 246-101-010
Definitions within the notifiable
conditions regulations.
The following definitions apply in
the interpretation and enforcement of this chapter:
(1) "Associated death" means a death resulting directly or indirectly from the confirmed condition of influenza or varicella. There should be no period of complete recovery between the illness and death.
(2) "Blood lead level" means a measurement of lead content in whole blood.
(((2))) (3) "Board" means the Washington state board of
health.
(((3))) (4) "Carrier" means a person harboring a specific
infectious agent and serving as a potential source of
infection to others.
(((4))) (5) "Case" means a person, alive or dead,
diagnosed with a particular disease or condition by a health
care provider with diagnosis based on clinical or laboratory
criteria or both.
(((5))) (6) "Child day care facility" means an agency
regularly providing care for a group of children for less than
twenty-four hours a day and subject to licensing under chapter 74.15 RCW.
(((6))) (7) "Condition notifiable within three ((work))
business days" means a notifiable condition that must be
reported to the local health officer or the department within
three ((working)) business days following date of diagnosis. For example, if a condition notifiable within three ((work))
business days is diagnosed on a Friday afternoon, the report
must be submitted by the following Wednesday.
(((7))) (8) "Communicable disease" means a disease caused
by an infectious agent ((which)) that can be transmitted from
one person, animal, or object to another person by direct or
indirect means including transmission ((via)) through an
intermediate host or vector, food, water, or air.
(((8) "Communicable disease cluster" means two or more
cases of a confirmed or suspected communicable disease with a
suspected common source diagnosed or exposed within a
twenty-four hour period.))
(9) "Contact" means a person exposed to an infected person, animal, or contaminated environment that may lead to infection.
(10) "Department" means the Washington state department of health.
(11) "Disease of suspected bioterrorism origin" means a disease caused by viruses, bacteria, fungi, or toxins from living organisms that are used to produce death or disease in humans, animals, or plants. Many of these diseases may have nonspecific presenting symptoms. The following situations could represent a possible bioterrorism event and should be reported immediately to the local health department:
(a) A single diagnosed or strongly suspected case of disease caused by an uncommon agent or a potential agent of bioterrorism occurring in a patient with no known risk factors;
(b) A cluster of patients presenting with a similar syndrome that includes unusual disease characteristics or unusually high morbidity or mortality without obvious etiology; or
(c) Unexplained increase in a common syndrome above seasonally expected levels.
(12) "Elevated blood lead level" means blood lead levels equal to or greater than 25 micrograms per deciliter for persons aged fifteen years or older, or equal to or greater than 10 micrograms per deciliter in children less than fifteen years of age.
(13) "Emerging condition with outbreak potential" means a newly identified condition with potential for person-to-person transmission.
(14) "Food service establishment" means a place, location, operation, site, or facility where food is manufactured, prepared, processed, packaged, dispensed, distributed, sold, served, or offered to the consumer regardless of whether or not compensation for food occurs.
(((14))) (15) "Health care-associated infection" means an
infection acquired in a health care facility.
(16) "Health care facility" means:
(a) Any ((facility or institution)) boarding home
licensed under chapter 18.20 RCW((, Boarding homes)); birthing
center licensed under chapter 18.46 RCW((, Birthing centers));
nursing home licensed under chapter 18.51 RCW((, Nursing
homes)); hospital licensed under chapter 70.41 RCW((,
Hospitals)); adult family home licensed under chapter 70.128 RCW((, Adult family homes)); ambulatory surgical facility
licensed under chapter 70.230 RCW; or private establishment
licensed under chapter 71.12 RCW((, Private establishments));
(b) Clinics, or other settings where one or more health care providers practice; and
(c) In reference to a sexually transmitted disease, other settings as defined in chapter 70.24 RCW.
(((15))) (17) "Health care provider" means any person
having direct or supervisory responsibility for the delivery
of health care who is:
(a) Licensed or certified in this state under Title 18 RCW; or
(b) Military personnel providing health care within the state regardless of licensure.
(((16))) (18) "Health care services to the patient" means
treatment, consultation, or intervention for patient care.
(((17))) (19) "Health carrier" means a disability insurer
regulated under chapter 48.20 or 48.21 RCW, a health care
service contractor as defined in RCW 48.44.010, or a health
maintenance organization as defined in RCW 48.46.020.
(((18))) (20) "HIV testing" means conducting a laboratory
test or sequence of tests to detect the human immunodeficiency
virus (HIV) or antibodies to HIV performed in accordance with
requirements to WAC 246-100-207. To assure that the
protection, including, but not limited to, pre- and post-test
counseling, consent, and confidentiality afforded to HIV
testing as described in chapter 246-100 WAC also applies to
the enumeration of CD4 + (T4) lymphocyte counts (CD4 + counts)
and CD4 + (T4) percents of total lymphocytes (CD4 + percents)
when used to diagnose HIV infection, CD4 + counts and
CD4 + percents will be presumed HIV testing except when shown
by clear and convincing evidence to be for use in the
following circumstances:
(a) Monitoring previously diagnosed infection with HIV;
(b) Monitoring organ or bone marrow transplants;
(c) Monitoring chemotherapy;
(d) Medical research; or
(e) Diagnosis or monitoring of congenital immunodeficiency states or autoimmune states not related to HIV.
The burden of proving the existence of one or more of the circumstances identified in (a) through (e) of this subsection shall be on the person asserting the existence.
(((19))) (21) "Immediately notifiable condition" means a
notifiable condition of urgent public health importance, a
case or suspected case of which must be reported to the local
health officer or the department ((immediately)) without delay
at the time of diagnosis or suspected diagnosis, twenty-four
hours a day, seven days a week.
(((20))) (22) "Infection control measures" means the
management of infected persons, or of a person suspected to be
infected, and others in a manner to prevent transmission of
the infectious agent.
(((21))) (23) "Institutional review board" means any
board, committee, or other group formally designated by an
institution, or authorized under federal or state law, to
review, approve the initiation of, or conduct periodic review
of research programs to assure the protection of the rights
and welfare of human research subjects as defined in RCW 70.02.010.
(((22))) (24) "Isolation" means the separation or
restriction of activities of infected individuals, or of
persons suspected to be infected, from other persons to
prevent transmission of the infectious agent.
(((23))) (25) "Laboratory" means any facility licensed as
a medical test site under chapter 70.42 RCW.
(((24))) (26) "Laboratory director" means the director or
manager, by whatever title known, having the administrative
responsibility in any licensed medical test site.
(((25))) (27) "Local health department" means the city,
town, county, or district agency providing public health
services to persons within the area, established under
chapters 70.05, 70.08, and 70.46 RCW.
(((26))) (28) "Local health officer" means the individual
having been appointed under chapter 70.05 RCW as the health
officer for the local health department, or having been
appointed under chapter 70.08 RCW as the director of public
health of a combined city-county health department.
(((27))) (29) "Member of the general public" means any
person present within the boundary of the state of Washington.
(((28))) (30) "Monthly notifiable condition" means a
notifiable condition which must be reported to the local
health officer or the department within one month of
diagnosis.
(((29) "Nosocomial infection" means an infection acquired
in a hospital or other health care facility.
(30))) (31) "Notifiable condition" means a disease or condition of public health importance, a case of which, and for certain diseases, a suspected case of which, must be brought to the attention of the local health officer or the state health officer.
(((31))) (32) "Other rare diseases of public health
significance" means a disease or condition, of general or
international public health concern, which is occasionally or
not ordinarily seen in the state of Washington including, but
not limited to, ((viral hemorrhagic fevers, Rocky Mountain))
spotted fever((,)) rickettsioses, babesiosis, tick paralysis,
anaplasmosis, and other tick borne diseases. This also
includes ((a)) public health events of international concern
and communicable diseases that would be of general public
concern if detected in Washington.
(((32))) (33) "Outbreak" means the occurrence of cases or
suspected cases of a disease or condition in any area over a
given period of time in excess of the expected number of
cases.
(((33))) (34) "Patient" means a case, suspected case, or
contact.
(((34))) (35) "Pesticide poisoning" means the disturbance
of function, damage to structure, or illness in humans
resulting from the inhalation, absorption, ingestion of, or
contact with any pesticide.
(((35))) (36) "Principal health care provider" means the
attending health care provider recognized as primarily
responsible for diagnosis or treatment of a patient, or in the
absence of such, the health care provider initiating
diagnostic testing or treatment for the patient.
(((36))) (37) "Public health authorities" means local
health departments, the state health department, and the
department of labor and industries personnel charged with
administering provisions of this chapter.
(((37))) (38) "Quarantine" means the separation or
restriction on activities of an individual having been exposed
to or infected with an infectious agent, to prevent disease
transmission.
(((38))) (39) "School" means a facility for programs of
education as defined in RCW 28A.210.070 (preschool and
kindergarten through grade twelve).
(((39))) (40) "Sexually transmitted disease (STD)" means
a bacterial, viral, fungal, or parasitic disease or condition
which is usually transmitted through sexual contact,
including:
(a) Acute pelvic inflammatory disease;
(b) Chancroid;
(c) Chlamydia trachomatis infection;
(d) Genital and neonatal Herpes simplex;
(e) Genital human papilloma virus infection;
(f) Gonorrhea;
(g) Granuloma inguinale;
(h) Hepatitis B infection;
(i) Human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS);
(j) Lymphogranuloma venereum;
(k) Nongonococcal urethritis (NGU); and
(l) Syphilis.
(((40))) (41) "State health officer" means the person
designated by the secretary of the department to serve as
statewide health officer, or, in the absence of this
designation, the person having primary responsibility for
public health matters in the state.
(((41))) (42) "Suspected case" means a person whose
diagnosis is thought likely to be a particular disease or
condition with suspected diagnosis based on signs and
symptoms, laboratory evidence, or both.
(((42))) (43) "Third-party payor" means an insurer
regulated under Title 48 RCW authorized to transact business
in this state or other jurisdiction((,)) including a health
care service contractor((,)) and health maintenance
organization((; or)), an employee welfare benefit plan((;)),
or a state or federal health benefit program as defined in RCW 70.02.010.
(((43))) (44) "Unexplained critical illness or death"
means cases of illness or death with infectious hallmarks but
no known etiology, in previously healthy persons one to
forty-nine years of age excluding those with chronic medical
conditions (e.g., malignancy, diabetes, AIDS, cirrhosis).
(((44))) (45) "Veterinarian" means an individual licensed
and practicing under provisions of chapter 18.92 RCW,
Veterinary medicine, surgery, and dentistry ((and practicing
animal health care)).
[Statutory Authority: RCW 43.20.050. 00-23-120, § 246-101-010, filed 11/22/00, effective 12/23/00.]
(1) The state health officer may:
(a) Request reporting of cases and suspected cases of disease and conditions in addition to those required in Tables HC-1 of WAC 246-101-101, Lab-1 of WAC 246-101-201, and HF-1 of WAC 246-101-301 on a provisional basis for a period of time less than forty-eight months when:
(i) The disease or condition is newly recognized or recently acknowledged as a public health concern;
(ii) Epidemiological investigation based on notification of cases may contribute to understanding of the disease or condition;
(iii) There is reason to expect that the information acquired through notification will assist the state and/or local health department to design or implement intervention strategies that will result in an improvement in public health; and
(iv) Written notification is provided to all local health officers regarding:
(A) Additional reporting requirements; and
(B) Rationale or justification for specifying the disease or condition as notifiable.
(b) Request laboratories to submit specimens indicative of infections in addition to those required in Table Lab-1 of WAC 246-101-201 on a provisional basis for a period of time less than forty-eight months, if:
(i) The infection is of public health concern;
(ii) The department has a plan for using data gathered from the specimens; and
(iii) Written notification is provided to all local health officers and all laboratory directors explaining:
(A) Actions required; and
(B) Reason for the addition.
(2) Within forty months of the state health officer's
designation of a condition as provisionally notifiable in
subsection (1)(a) of this section, or requests for
laboratories to submit specimens indicative of infections in
subsection (((2))) (1)(b) of this section, the department will
conduct an evaluation for the notification requirement that:
(a) Estimates the societal cost resulting from the provisionally notifiable condition;
(i) Determine the prevalence of the provisional notifiable condition; and
(ii) Identify the quantifiable costs resulting from the provisionally notifiable condition; and
(iii) Discuss the qualitative costs resulting from the provisionally notifiable condition.
(b) Describes how the information was used and how it will continue to be used to design and implement intervention strategies aimed at combating the provisionally notifiable condition;
(c) Verifies the effectiveness of previous intervention strategies at reducing the incidence, morbidity, or mortality of the provisional notifiable condition;
(d) Identifies the quantitative and qualitative costs of the provisional notification requirement;
(e) Compares the costs of the provisional notification requirement with the estimated cost savings resulting from the intervention based on the information provided through the provisional notification requirement;
(f) Describes the effectiveness and utility of using the notifiable conditions process as a mechanism to collect these data; and
(g) Describes that a less burdensome data collection system (example: Biennial surveys) would not provide the information needed to effectively establish and maintain the intervention strategies.
(3) Based upon the evaluation in subsection (2) of this section, the board will assess results of the evaluation after the particular condition is notifiable or the requirement for laboratories to submit specimens indicative of infections has been in place for no longer than forty months. The board will determine based upon the results of the evaluation whether the provisionally notifiable condition or the requirement for laboratories to submit specimens indicative of infections should be:
(a) Permanently notifiable in the same manner as the provisional notification requirement;
(b) Permanently notifiable in a manner that would use the evaluation results to redesign the notification requirements; or
(c) Deleted from the notifiable conditions system.
(4) The department shall have the authority to declare an emergency and institute notification requirements under the provisions of RCW 34.05.350.
[Statutory Authority: RCW 43.20.050, 70.24.125. 05-03-055, § 246-101-015, filed 1/11/05, effective 2/11/05. Statutory Authority: RCW 43.20.050. 00-23-120, § 246-101-015, filed 11/22/00, effective 12/23/00.]
(1) Principal health care providers shall notify public
health authorities of ((these)) the conditions identified in
Table HC-1 of this section as individual case reports ((using
procedures described throughout this chapter)) following the
requirements in WAC 246-101-105, 246-101-110, 246-101-115, and
246-101-120.
(2) Other health care providers in attendance, other than
the principal health care provider, shall notify public health
authorities of the ((following notifiable)) conditions((,))
identified in Table HC-1 of this section unless the condition
notification has already been made.
(3) Local health officers may require additional conditions to be notifiable within the local health officer's jurisdiction.
((WAC 246-101-105, 246-101-110, 246-101-115, and
246-101-120 also include requirements for how notifications
shall be made, when they shall be made, the content of these
notifications, and how information regarding notifiable
conditions cases must be handled and may be disclosed.))
Table HC-1 (Conditions Notifiable by Health Care Providers)
Notifiable Condition | Time Frame for Notification | Notifiable to Local Health Department | Notifiable to State Department of Health |
Acquired Immunodeficiency Syndrome (AIDS) | Within 3 (( |
√ | |
(( |
|||
Anthrax | Immediately | √ | |
Arboviral Disease (acute disease only including, but not limited to, West Nile virus, eastern and western equine encephalitis, dengue, St. Louis encephalitis, La Crosse encephalitis, Japanese encephalitis, and Powassan) | Within 3 (( |
√ | |
Asthma, occupational | Monthly | √ | |
Birth Defects – Autism Spectrum Disorders | Monthly | √ | |
Birth Defects – Cerebral Palsy | Monthly | √ | |
Birth Defects – Alcohol Related Birth Defects | Monthly | √ | |
Botulism (foodborne, infant, and wound) | Immediately | √ | |
Brucellosis (Brucella species) | (( |
√ | |
Burkholderia mallei (Glanders) and pseudomallei (Melioidosis) | Immediately | √ | |
Campylobacteriosis | Within 3 (( |
√ | |
Chancroid | Within 3 (( |
√ | |
Chlamydia trachomatis infection | Within 3 (( |
√ | |
Cholera | Immediately | √ | |
Cryptosporidiosis | Within 3 (( |
√ | |
Cyclosporiasis | Within 3 (( |
√ | |
Diphtheria | Immediately | √ | |
Disease of suspected bioterrorism origin
(( • Anthrax • Smallpox)) |
Immediately | √ | |
(( |
|||
Domoic acid poisoning | Immediately | √ | |
E. coli – Refer to "Shiga toxin-producing E. coli" | Immediately | √ | |
Emerging condition with outbreak potential | Immediately | √ | |
Giardiasis | Within 3 (( |
√ | |
Gonorrhea | Within 3 (( |
√ | |
Granuloma inguinale | Within 3 (( |
√ | |
Haemophilus influenzae (invasive disease, children under age 5) | Immediately | √ | |
Hantavirus pulmonary syndrome | Within (( |
√ | |
(( |
|||
Hepatitis A (acute infection) | (( |
√ | |
Hepatitis B (acute infection) | Within (( |
√ | |
Hepatitis B surface antigen + pregnant women | Within 3 (( |
√ | |
Hepatitis B (chronic infection) – Initial diagnosis, and previously unreported prevalent cases | Monthly | √ | |
Hepatitis C (acute infection) | Within 3 business days | √ | |
Hepatitis C (( |
Monthly | √ | |
(( |
|||
Hepatitis D (acute and chronic infection) | Within 3 business days | √ | |
Hepatitis E (acute infection) | Within 24 hours | √ | |
Herpes simplex, neonatal and genital (initial infection only) | Within 3 (( |
√ | |
Human immunodeficiency virus (HIV) infection | Within 3 (( |
√ | |
Influenza, novel or unsubtypable strain | Immediately | √ | |
Influenza-associated death (lab confirmed) | Within 3 business days | √ | |
Legionellosis | Within (( |
√ | |
Leptospirosis | Within (( |
√ | |
Listeriosis | (( |
√ | |
Lyme Disease | Within 3 (( |
√ | |
Lymphogranuloma venereum | Within 3 (( |
√ | |
Malaria | Within 3 (( |
√ | |
Measles (rubeola) – acute disease only | Immediately | √ | |
Meningococcal disease (invasive) | Immediately | √ | |
Monkeypox | Immediately | √ | |
Mumps (acute disease only) | Within (( |
√ | |
Outbreaks of suspected foodborne origin | Immediately | √ | |
Outbreaks of suspected waterborne origin | Immediately | √ | |
Paralytic shellfish poisoning | Immediately | √ | |
Pertussis | (( |
√ | |
Pesticide poisoning (hospitalized, fatal, or cluster) | Immediately | √ | |
Pesticide poisoning (all other) | Within 3 (( |
√ | |
Plague | Immediately | √ | |
Poliomyelitis | Immediately | √ | |
Prion disease | Within 3 business days | √ | |
Psittacosis | Within (( |
√ | |
Q Fever | Within (( |
√ | |
Rabies (Confirmed Human or Animal) | Immediately | √ | |
Rabies (( |
(( |
√ | |
Relapsing fever (borreliosis) | (( |
√ | |
Rubella (including congenital rubella syndrome) (acute disease only) | Immediately | √ | |
Salmonellosis | (( |
√ | |
SARS | Immediately | √ | |
Serious adverse reactions to immunizations | Within 3 (( |
√ | |
Shiga toxin-producing E. coli infections (enterohemorrhagic E. coli including, but not limited to, E. coli O157:H7) | Immediately | √ | |
Shigellosis | Immediately | √ | |
Smallpox | Immediately | √ | |
Syphilis | Within 3 (( |
√ | |
Tetanus | Within 3 (( |
√ | |
Trichinosis | Within 3 (( |
√ | |
Tuberculosis | Immediately | √ | |
Tularemia | (( |
√ | |
(( |
|||
Vaccinia transmission | Immediately | √ | |
Vancomycin-resistant Staphylococcus aureus (not to include vancomycin-intermediate) | Within 24 hours | √ | |
Varicella-associated death | Within 3 business days | √ | |
Vibriosis | Within (( |
√ | |
Viral hemorrhagic fever | Immediately | √ | |
Yellow fever | Immediately | √ | |
Yersiniosis | Within (( |
√ | |
Other rare diseases of public health significance | (( |
√ | |
Unexplained critical illness or death | (( |
√ |
(√) Indicates which agency should receive case and suspected case reports. |
[Statutory Authority: RCW 43.20.050, 70.24.125. 05-03-055, § 246-101-101, filed 1/11/05, effective 2/11/05. Statutory Authority: RCW 43.20.050, 70.24.125 and 70.28.010. 00-23-120, § 246-101-101, filed 11/22/00, effective 12/23/00.]
(1) Notify the local health department where the patient
resides ((()), or, in the event that patient residence cannot
be determined, ((notify)) the local health department
((where)) in which the health care providers practice(())),
regarding:
(a) Cases or suspected cases of notifiable conditions specified as notifiable to local health departments in Table HC-1 of WAC 246-101-101;
(b) Cases of conditions designated as notifiable by the local health officer within that health officer's jurisdiction;
(c) Outbreaks or suspected outbreaks of disease((. These
patterns include)) including, but ((are)) not limited to,
suspected or confirmed outbreaks of ((chickenpox)) varicella,
influenza, viral meningitis, ((nosocomial)) health
care-associated infection suspected due to contaminated food
products or devices, or environmentally related disease;
(d) Known barriers which might impede or prevent compliance with orders for infection control or quarantine; and
(e) Name, address, and other pertinent information for any case, suspected case or carrier refusing to comply with prescribed infection control measures.
(2) Notify the department ((of health)) of conditions
designated as notifiable to the local health department when:
(a) A local health department is closed or representatives of the local health department are unavailable at the time a case or suspected case of an immediately notifiable condition occurs;
(b) A local health department is closed or representatives of the local health department are unavailable at the time an outbreak or suspected outbreak of communicable disease occurs.
(3) Notify the department of pesticide poisoning that is fatal, causes hospitalization or occurs in a cluster.
(4) Notify the department ((as specified in Table HC-1))
regarding cases of notifiable conditions specified as
notifiable to the department in Table HC-1 of WAC 246-101-101.
(5) Assure that positive ((cultures and)) preliminary
test results and positive final test results for notifiable
conditions of specimens referred to laboratories outside of
Washington for testing are correctly notified to the local
health department of the patient's residence or the department
as specified in Table Lab-1 of WAC 246-101-201. This
requirement can be satisfied by:
(a) Arranging for the referral laboratory to notify either the local health department, the department, or both; or
(b) Forwarding the notification of the test result from the referral laboratory to the local health department, the department, or both.
(6) Cooperate with public health authorities during investigation of:
(a) Circumstances of a case or suspected case of a notifiable condition or other communicable disease; and
(b) An outbreak or suspected outbreak of disease.
(7) Provide adequate and understandable instruction in disease control measures to each patient who has been diagnosed with a case of a communicable disease, and to contacts who may have been exposed to the disease.
(8) Maintain responsibility for deciding date of discharge for hospitalized tuberculosis patients.
(9) Notify the local health officer of intended discharge of tuberculosis patients in order to assure appropriate outpatient arrangements are arranged.
(10) By July 1, 2011, when ordering a laboratory test for a notifiable condition as identified in Table HC-1 of WAC 246-101-101, providers must provide the laboratory with the following information for each test order:
(a) Patient name;
(b) Patient address including zip code;
(c) Patient date of birth;
(d) Patient sex;
(e) Name of the principal health care provider;
(f) Telephone number of the principal health care provider;
(g) Type of test requested;
(h) Type of specimen;
(i) Date of ordering specimen collection.
[Statutory Authority: RCW 43.20.050 and 70.104.030. 00-23-120, § 246-101-105, filed 11/22/00, effective 12/23/00.]
(a))) Health care providers shall adhere to the following timelines and procedures:
(1) Conditions designated as immediately notifiable must
be reported ((by telephone or by secure facsimile copy of a
written case report)) to the local health officer or the
department, as specified in Table HC-1((;
(b))) of WAC 246-101-101, immediately as the time of diagnosis or suspected diagnosis. This applies twenty-four hours a day, seven days a week. Each local health jurisdiction, as well as the department, maintains after-hours emergency phone contacts for this purpose. A party sending a report by secure facsimile copy or secure electronic transmission during normal business hours must confirm immediate receipt by a live person.
(2) Conditions designated as notifiable within twenty-four hours must be reported to the local health officer or the department, as specified in Table HC-1 of WAC 246-101-101, within twenty-four hours of diagnosis or suspected diagnosis, seven days a week. Reports during normal public health business hours may be sent by secure electronic transmission, telephone, or secure facsimile copy of a case report. A party sending a report outside of normal public health business hours must use the after-hours emergency phone contact for the appropriate jurisdiction.
(3) Conditions designated as notifiable within three
((working)) business days must be reported to the local health
officer or department, as specified in Table HC-1 of WAC 246-101-101, within three business days. Notification may be
sent by written case report, secure electronic transmission,
telephone, or secure facsimile copy ((to the local health
officer or department as specified in Table HC-1)) of a case
report; and
(((c))) (4) Conditions designated as notifiable on a
monthly basis must be reported to the local health officer or
the department, as specified in Table HC-1 of WAC 246-101-101,
on a monthly basis. Notification may be sent by written case
report, secure electronic transmission, telephone, or secure
facsimile copy ((to the local health officer or the department
as specified in Table HC-1.
(2) The local health officer may authorize notifications by telephone or secure electronic transmission for cases and suspected cases of notifiable conditions specified as notifiable to local health departments.
(3) The state health officer may authorize notifications by telephone or secure electronic transmission for cases and suspected cases of notifiable conditions specified as notifiable to the department)) of a case report.
[Statutory Authority: RCW 43.20.050, 70.24.125, 70.28.010 and 70.104.030. 00-23-120, § 246-101-110, filed 11/22/00, effective 12/23/00.]
(a) Patient name;
(b) Patient address;
(c) Patient telephone number;
(d) Patient date of birth;
(e) Patient sex;
(f) Diagnosis or suspected diagnosis of disease or condition;
(g) Pertinent laboratory data, if available;
(h) Name ((and address or telephone number)) of the
principal health care provider;
(i) Telephone number of the principal health care provider;
(j) Address of the principal health care provider;
(k) Name and ((address or)) telephone number of the
person providing the report; and
(((j))) (l) Other information as the department may
require on forms generated by the department.
(2) The local health officer or state health officer may require other information of epidemiological or public health value.
[Statutory Authority: RCW 43.20.050, 43.70.545, 70.24.125, 70.28.010 and 70.104.030. 00-23-120, § 246-101-115, filed 11/22/00, effective 12/23/00.]
(2) Health care providers who know of a person with a notifiable condition, other than a sexually transmitted disease, shall release identifying information only to other individuals responsible for protecting the health and well-being of the public through control of disease, including the local health department.
(3) Health care providers with knowledge of a person with sexually transmitted disease, and following the basic principles of health care providers, which respect the human dignity and confidentiality of patients:
(a) May disclose the identity of a person or release identifying information only as specified in RCW 70.24.105; and
(b) Shall under RCW 70.24.105(6), use only the following customary methods for exchange of medical information:
(i) Health care providers may exchange medical information related to HIV testing, HIV test results, and confirmed HIV or confirmed STD diagnosis and treatment in order to provide health care services to the patient. This means that information shared impacts the care or treatment decisions concerning the patient; and the health care provider requires the information for the patient's benefit.
(ii) Health care providers responsible for office management are authorized to permit access to a patient's medical information and medical record by medical staff or office staff to carry out duties required for care and treatment of a patient and the management of medical information and the patient's medical record.
(c) Health care providers conducting a clinical HIV research project shall report the identity of an individual participating in the project unless:
(i) The project has been approved by an institutional review board; and
(ii) The project has a system in place to remind referring health care providers of their reporting obligations under this chapter.
(4) Health care providers shall establish and implement policies and procedures to maintain confidentiality related to a patient's medical information.
[Statutory Authority: RCW 43.20.050 and 70.104.030. 00-23-120, § 246-101-120, filed 11/22/00, effective 12/23/00.]
(1) Laboratory directors ((must)) shall notify public
health authorities of positive ((cultures and)) preliminary
test results and positive final test results of the conditions
identified in Table Lab-1 of this section as individual case
reports and provide specimen submissions ((using procedures
described throughout this chapter)) following the requirements
in WAC 246-101-205, 246-101-210, 246-101-215, 246-101-220,
246-101-225, and 246-101-230.
(2) Local health officers may require additional conditions to be notifiable within the local health officer's jurisdiction.
((WAC 246-101-205, 246-101-210, 246-101-215, 246-101-220,
246-101-225, and 246-101-230 also include requirements for how
notifications and specimen submissions are made, when they are
made, the content of these notifications and specimen
submissions, and how information regarding notifiable
conditions cases must be handled and may be disclosed.))
Table Lab-1 (Conditions Notifiable by Laboratory Directors)
Notifiable Condition | Time Frame for Notification | Notifiable to Local Health Department | Notifiable to Department of Health | Specimen Submission to Department of Health (Type & Timing) | |
(( (West Nile virus, eastern and western equine encephalitis, dengue, St. Louis encephalitis, La Crosse encephalitis, Japanese encephalitis, Powassan, California serogroup, Chikungunya) |
2 business days | √ | On request | ||
Acute: IgM positivity PCR positivity Viral isolation |
|||||
Bacillus anthracis (Anthrax) | Immediately | √ | Culture (2 business days) | ||
Blood Lead Level | Elevated Levels
– 2 business
days Nonelevated Levels – Monthly |
√ | |||
(( |
|||||
Bordetella pertussis (Pertussis) | 2 business days | √ | Culture, when available (2 business days) | ||
Borrelia burgdorferi (Lyme disease) | 2 business days | √ | On request | ||
Borrelia hermsii or recurrentis (Relapsing fever, tick- or louse-borne) | 2 business days | √ | On request | ||
Brucella species
(Brucellosis)
(( |
(( |
√ | (( |
||
Burkholderia mallei and pseudomallei | Immediately | √ | Culture (2 business days); additional specimens when available | ||
Campylobacter species (Campylobacteriosis) | 2 business days | √ | On request | ||
CD4 + (T4) lymphocyte counts and/or CD4 + (T4) (patients aged thirteen or older) | Monthly | Only when the local health department is designated by the Department of Health | √ (Except King County) | ||
Chlamydia psittaci (Psittacosis) | Within 24 hours | √ | On request | ||
Chlamydia
trachomatis
(( |
2 business days | √ | |||
(( |
|||||
Clostridium botulinum (Botulism) | Immediately | √ | Serum and/or stool; any other specimens available (i.e., foods submitted for suspected foodborne case; debrided tissue submitted for suspected wound botulism) (2 business days) | ||
Corynebacterium diphteriae (Diphtheria) | Immediately | √ | Culture (2 business days) | ||
Coxiella burnetti (Q fever) | Within 24 hours | √ | Culture (2 business days) | ||
Cryptococcus non v. neoformans | N/A | N/A | Culture (2 business days) or other specimens upon request | ||
Cryptosporidium (Cryptosporidiosis) | 2 business days | √ | On request | ||
Cyclospora cayetanenis (Cyclosporiasis) | 2 business days | √ | Specimen (2 business days) | ||
(( |
|||||
• Anthrax • Smallpox |
|||||
E. coli – Refer to "Shiga toxin-producing E. coli" | Immediately | √ | |||
Francisella tularensis (Tularemia) | Immediately | √ | Culture or other appropriate clinical material (2 business days) | ||
Giardia lamblia (Giardiasis) | 2 business days | √ | On request | ||
Haemophilus influenzae (children < 5 years of age) | Immediately | √ | Culture, from sterile sites only, when type is unknown (2 business days) | ||
Hantavirus | Within 24 hours | √ | On request | ||
Hepatitis A (( (Hepatocellular enzyme levels to accompany report) |
(( |
√ | On request | ||
Hepatitis B virus (acute) by IgM positivity | Within 24 hours | √ | On request | ||
Hepatitis B virus | Monthly | √ | |||
– HBsAg (Surface antigen) | |||||
– HBeAg (E antigen) | |||||
– HBV DNA | |||||
Hepatitis C virus | Monthly | √ | |||
Hepatitis D virus | 2 business days | √ | On request | ||
Hepatitis E virus | Within 24 hours | √ | On request | ||
Human immunodeficiency virus (HIV) infection (for example, positive Western Blot assays, P24 antigen or viral culture tests) | 2 business days | Only when the local health department is designated by the Department of Health | √ (Except King County) | ||
Human immunodeficiency virus (HIV) infection (ll viral load detection test results - detectable and undetectable) | Monthly | Only when the local health department is designated by the Department of Health | √ (Except King County) | ||
Influenza virus, novel or unsubtypable strain | Immediately | √ | Isolate or clinical specimen (2 business days) | ||
Legionella species (Legionellosis) | Within 24 hours | √ | Culture (2 business days) | ||
Leptospira species (Leptospirosis) | Within 24 hours | √ | On request | ||
Listeria
monocytogenes (Listeriosis) |
(( |
√ | Culture (2 business days) | ||
Measles virus (rubeola) Acute: IgM positivity PCR positivity |
Immediately | √ | (( |
||
(( |
|||||
Mumps virus Acute: IgM positivity PCR positivity |
Within 24 hours | √ | Isolate or clinical specimen associated with positive result (2 business days) | ||
Mycobacterium tuberculosis (Tuberculosis) | 2 business days | √ | Culture (2 business days) | ||
Mycobacterium tuberculosis (Tuberculosis) (Antibiotic sensitivity for first isolates) | 2 business days | √ | |||
Neisseria gonorrhoeae (Gonorrhea) | 2 business days | √ | |||
Neisseria meningitidis (Meningococcal disease) | Immediately | √ | Culture (from sterile sites only) (2 business days) | ||
Plasmodium species (Malaria) | 2 business days | √ | On request | ||
Poliovirus Acute: IgM positivity PCR positivity |
Immediately | √ | Isolate or clinical specimen associated with positive result (2 business days) | ||
Rabies virus (human or animal) | Immediately | √ (Pathology Report Only) | (( |
||
Salmonella species (Salmonellosis) | (( |
√ | Culture (2 business days) | ||
SARS-associated coronavirus | Immediately | √ | Isolate or clinical specimen associated with positive result (2 business days) | ||
Shiga toxin-producing E. coli (enterohemorrhagic E. coli including, but not limited to, E. coli O157:H7) | Immediately | √ | Culture (2 business days) or specimen if no culture is available | ||
Shigella species (Shigellosis) | (( |
√ | Culture (2 business days) | ||
Treponema pallidum (Syphilis) | 2 business days | √ | Serum (2 business days) | ||
(( |
|||||
Trichinella species | 2 business days | √ | On request | ||
Vancomycin-resistant Staphylococcus aureus | Within 24 hours | √ | Culture (2 business days) | ||
Variola virus (smallpox) | Immediately | √ | Isolate or clinical specimen associated with positive result (2 business days) | ||
Vibrio cholerae O1 or O139 (Cholera) | Immediately | √ | Culture (2 business days) | ||
Vibrio species (Vibriosis) | Within 24 hours | √ | Culture (2 business days) | ||
Viral hemorrhagic fever: Arenaviruses Bunyaviruses Filoviruses Flaviviruses |
Immediately | √ | Isolate or clinical specimen associated with positive result (2 business days) | ||
Yellow fever virus | Immediately | √ | Serum (2 business days) | ||
Yersinia enterocolitica or pseudotuberculosis | Within 24 hours | √ | On request | ||
Yersinia pestis (Plague) | Immediately | √ | Culture or other appropriate clinical material (2 business days) |
(√) Indicates which agency should receive case and suspected case reports. |
(1))) (3) The local health department may request laboratory reporting of additional test results pertinent to an investigation of a notifiable condition (i.e., hepatocellular enzyme levels for hepatitis or negative stool test results on salmonellosis rescreening).
(4) Laboratory directors may notify ((either)) the local
health department((s or)), the department, or both of other
laboratory results ((through cooperative agreement.
(2) Laboratory directors may submit malaria cultures to the state public health laboratories)).
[Statutory Authority: RCW 70.24.125. 06-16-117, § 246-101-201, filed 8/1/06, effective 9/1/06. Statutory Authority: RCW 43.20.050, 70.24.125. 05-03-055, § 246-101-201, filed 1/11/05, effective 2/11/05. Statutory Authority: RCW 43.20.050, 70.24.125 and 70.28.010. 00-23-120, § 246-101-201, filed 11/22/00, effective 12/23/00.]
(((1))) (a) Notify the local health department where the
patient resides ((()), or, in the event that patient residence
cannot be determined, ((notify)) the local health department
((where)) in which the ordering health care provider
practices, or the local health department in which the
laboratory ((is located))) operates, regarding:
(((a))) (i) Positive ((cultures and)) preliminary test
results and positive final test results of notifiable
conditions specified as notifiable to the local health
department in Table Lab-1.
(((b))) (ii) Positive ((cultures and)) preliminary test
results and positive final test results of conditions
specified as notifiable by the local health officer within
that health officer's jurisdiction.
(((2) If the laboratory is unable to determine the local
health department of the patient's residence, the laboratory
director shall notify the local health department in which the
health care provider that ordered the laboratory test is
located.
(3))) (b) Notify the department ((of health)) of
conditions designated as notifiable to the local health
department when:
(((a))) (i) A local health department is closed or
representatives of the local health department are unavailable
at the time a positive ((culture or)) preliminary test result
or positive final test result((s)) of an immediately
notifiable condition occurs; or
(((b))) (ii) A local health department is closed or
representatives of the local health department are unavailable
at the time an outbreak or suspected outbreak of communicable
disease occurs.
(((4))) (c) Notify the department of positive ((cultures
and)) preliminary test results or positive final test results
for conditions designated notifiable to the department in
Table Lab-1.
(((5))) (d) Notify the department of nonelevated blood
lead levels on a monthly basis.
(((6))) (e) Submit specimens for conditions noted in
Table Lab-1 to the Washington state public health laboratories
or other laboratory designated by the state health officer for
diagnosis, confirmation, storage, or further testing.
(((7))) (f) Ensure that positive ((cultures and))
preliminary test results and positive final test results for
notifiable conditions of specimens referred to other
laboratories for testing are correctly notified to the correct
local health department or the department. This requirement
can be satisfied by:
(((a))) (i) Arranging for the referral laboratory to
notify either the local health department, the department, or
both; or
(((b))) (ii) Forwarding the notification of the test
result from the referral laboratory to the local health
department, the department, or both.
(((8))) (g) Cooperate with public health authorities
during investigation of:
(((a))) (i) Circumstances of a case or suspected case of
a notifiable condition or other communicable disease; and
(((b))) (ii) An outbreak or suspected outbreak of
disease.
(((9))) (2) Laboratory directors may designate
responsibility for working and cooperating with public health
authorities to certain employees as long as designated
employees are:
(a) Readily available; and
(b) Able to provide requested information in a timely manner.
(3) By July 1, 2011, when referring a specimen to another laboratory for a test for a notifiable condition, laboratory directors shall provide the laboratory with the following information for each test referral:
(a) Patient name;
(b) Full address of patient, or patient zip code at a minimum, when available in laboratory data base;
(c) Date of birth or age of patient, when available in laboratory data base;
(d) Sex of patient, when available in laboratory data base;
(e) Name of the principal health care provider;
(f) Telephone number of the principal health care provider;
(g) Address of the principal health care provider, when available;
(h) Type of test requested;
(i) Type of specimen; and
(j) Date of specimen collection.
(4) By January 1, 2013, laboratory data bases must have the ability to receive, store, and retrieve all of the data elements specified in subsection (3)(a) through (j) of this section.
[Statutory Authority: RCW 43.20.050. 00-23-120, § 246-101-205, filed 11/22/00, effective 12/23/00.]
(1))) adhere to the following timelines and procedures:
(a) Specimens designated for submission within two business days must be in transit within two business days from the time the specimen is ready for packaging;
(b) Specimens designated for submission on request may be requested by the local health departments or the department. The laboratory shall ship a requested specimen within two business days of receiving the request, provided the specimen is still available at the time of the request. This is not intended to require laboratories to save specimens indefinitely in anticipation of a request.
(2) Local health jurisdictions may temporarily waive specimen submission for circumstances at their discretion by communication with individual laboratories.
(3) Laboratories located in King County shall forward required specimen submissions (except tuberculosis cultures) to:
Public Health Seattle and King County - Laboratory
325 9th Avenue
Box 359973
Seattle, WA 98104-2499
(((2))) (4) Laboratories located in King County shall
forward required tuberculosis cultures to:
Washington State Public Health Laboratories
Washington State Department of Health
1610 NE 150th Street
Seattle, WA 98155
(((3))) (5) Laboratories located outside of King County
shall forward all required specimen submissions to:
Washington State Public Health Laboratories
Washington State Department of Health
1610 NE 150th Street
Seattle, WA 98155
(((4))) (6) The state health officer may designate
additional laboratories as public health referral
laboratories.
[Statutory Authority: RCW 43.20.050, 70.24.125 and 70.28.010. 00-23-120, § 246-101-210, filed 11/22/00, effective 12/23/00.]
(1) Type of specimen tested;
(2) Name of reporting laboratory;
(3) Telephone number of reporting laboratory;
(4) Date of specimen ((collected)) collection;
(5) Requesting health care provider's name;
(6) Requesting health care provider's phone number ((or
address, or both));
(7) Requesting health care provider's address, when available;
(8) Test result;
(((8))) (9) Name of patient (((if available), or patient
identifier otherwise));
(((9))) (10) Sex of patient (((if)), when available(()))
in laboratory data base;
(((10))) (11) Date of birth or age of patient (((if)),
when available(())) in laboratory data base;
(((11))) (12) Full address of patient (((if)), or patient
zip code at a minimum, when available(())) in laboratory data
base;
(((12))) (13) Telephone number of patient (((if)), when
available(())) in laboratory data base;
(((13))) (14) Other information of epidemiological value
(((if)), when available(())).
[Statutory Authority: RCW 43.20.050, 70.24.125 and 70.28.010. 00-23-120, § 246-101-215, filed 11/22/00, effective 12/23/00.]
(a))) Laboratory directors shall adhere to the following timelines and procedures:
(1) Conditions designated as immediately notifiable must be reported to the local health officer or the department, as specified in Table Lab-1 of WAC 246-101-201, immediately at the time of positive preliminary test result or positive final test result. This applies twenty-four hours a day, seven days a week. Each local health jurisdiction, as well as the department, maintains after-hours emergency telephone contacts for this purpose. A party sending notification by secure facsimile copy or secure electronic transmission during normal business hours must confirm immediate receipt by a live person.
(2) Conditions designated as notifiable within twenty-four hours must be reported to the local health officer or the department, as specified in Table Lab-1 of WAC 246-101-201, within twenty-four hours of positive preliminary test result or positive final test result, seven days a week. Reports during normal public health business hours may be sent by secure electronic transmission, telephone, or secure facsimile copy of a case report. A party sending a report outside of normal public health business hours must use the after-hours emergency phone contact for the appropriate jurisdiction.
(3) Conditions designated as notifiable within two
business days must be reported to the local health officer or
the department, as specified in Table Lab-1 of WAC 246-101-201, within two business days. Notification may be
sent by ((written case report)) secure electronic
transmission, telephone, or secure facsimile copy ((to the
local health officer or the department as specified in Table
Lab-1 within two working days)) of a case report; and
(((b))) (4) Conditions designated as notifiable on a
monthly basis must be reported to the local health officer or
the department, as specified in Table Lab-1 of WAC 246-101-201, on a monthly basis. Notification may be sent by
written case report, secure electronic transmission,
telephone, or secure facsimile copy ((to the local health
officer or the department as specified in Table Lab-1.
(2) The local health officer may authorize notifications by telephone or secure electronic transmission for cases and suspected cases of notifiable conditions specified as notifiable to local health departments.
(3) The state health officer may authorize notifications by telephone or secure electronic transmission for cases and suspected cases of notifiable conditions specified as notifiable to the department)) of a case report.
[Statutory Authority: RCW 43.20.050, 70.24.125 and 70.28.010. 00-23-120, § 246-101-220, filed 11/22/00, effective 12/23/00.]
(a) Type of specimen tested;
(b) Name of reporting laboratory;
(c) Telephone number of reporting laboratory;
(d) Date of specimen ((collected)) collection;
(e) Date specimen received by reporting laboratory;
(f) Requesting health care provider's name;
(g) Requesting health care provider's phone number ((or
address, or both));
(h) Requesting health care provider's address, when available;
(i) Test result;
(((i))) (j) Name of patient (((if available), or patient
identifier otherwise));
(((j))) (k) Sex of patient (((if)), when available(()))
in laboratory data base;
(((k))) (l) Date of birth or age of patient (((if)), when
available(())) in laboratory data base; and
(((l) Other information of epidemiological value (if
available).)) (m) Full address of patient, or patient zip code
at a minimum, when available in laboratory data base.
(2) Local health officers and the state health officer may require laboratory directors to report other information of epidemiological or public health value.
[Statutory Authority: RCW 43.20.050, 43.70.545, 70.24.125 and 70.28.010. 00-23-120, § 246-101-225, filed 11/22/00, effective 12/23/00.]
(2) Laboratory directors shall establish and implement policies and procedures to maintain confidentiality related to a patient's medical information.
(3) Laboratory directors and personnel working in laboratories who know of a person with a notifiable condition, other than a sexually transmitted disease, shall release identifying information only to other individuals responsible for protecting the health and well-being of the public through control of disease.
(4) Laboratory directors and personnel working in laboratories with knowledge of a person with sexually transmitted disease, and following the basic principles of health care providers, which respect the human dignity and confidentiality of patients:
(a) May disclose identity of a person or release identifying information only as specified in RCW 70.24.105; and
(b) Shall under RCW 70.24.105(6), use only the following customary methods for exchange of medical information:
(i) Laboratory directors and personnel working in
laboratories may exchange medical information related to HIV
testing, HIV test results, and confirmed HIV or confirmed STD
diagnosis and treatment in order to provide health care
services to the patient. This means that information shared
impacts the care or treatment decisions concerning the
patient; and the laboratory director or personnel working in
the laboratory require((s)) the information for the patient's
benefit.
(ii) Laboratory directors are authorized to permit access
to a patient's medical information and medical record by
laboratory staff or office staff to carry out duties required
for care and treatment of a patient ((and)), the management of
medical information, and the management of the patient's
medical record.
[Statutory Authority: RCW 43.20.050. 00-23-120, § 246-101-230, filed 11/22/00, effective 12/23/00.]
(1) Health care facilities ((are required to)) shall
notify public health authorities of cases that occur in their
facilities of the conditions identified in Table HF-1 of this
section following the requirements in WAC 246-101-305,
246-101-310, 246-101-315, and 246-101-320. This is not
intended to require health care facilities to confirm the
absence of conditions listed in Table HF-1 in facility
patients.
(2) Health care facilities may choose to assume the notification for their health care providers for conditions designated in Table HF-1 of this section.
(3) Health care facilities may not assume the reporting requirements of laboratories that are components of the health care facility.
(4) Local health officers may require additional conditions to be notifiable within the local health officer's jurisdiction.
((WAC 246-101-305, 246-101-310, 246-101-315, and
246-101-320 also include requirements for how notifications
shall be made, when they are made, the content of these
notifications, and how information regarding notifiable
conditions cases must be handled and may be disclosed.))
Table HF-1 (Conditions Notifiable by Health Care Facilities)
Notifiable Condition | Time Frame for Notification | Notifiable to Local Health Department | Notifiable to State Department of Health |
Acquired Immunodeficiency Syndrome (AIDS) | Within 3 (( |
√ | |
(( |
|||
Anthrax | Immediately | √ | |
Arboviral Disease (acute disease only including, but not limited to, West Nile virus, eastern and western equine encephalitis, dengue, St. Louis encephalitis, La Crosse encephalitis, Japanese encephalitis, and Powassan) | Within 3 (( |
√ | |
Asthma, occupational | Monthly | √ | |
Birth Defects – Abdominal Wall Defects (inclusive of gastroschisis and omphalocele) | Monthly | √ | |
Birth Defects – Autism Spectrum Disorders | Monthly | √ | |
Birth Defects – Cerebral Palsy | Monthly | √ | |
Birth Defects – Down Syndrome | Monthly | √ | |
Birth Defects – Alcohol Related Birth Defects | Monthly | √ | |
Birth Defects – Hypospadias | Monthly | √ | |
Birth Defects – Limb reductions | Monthly | √ | |
Birth Defects – Neural Tube Defects (inclusive of anencephaly and spina bifida) | Monthly | √ | |
Birth Defects – Oral Clefts (inclusive of cleft lip with/without cleft palate) | Monthly | √ | |
Botulism (foodborne, infant, and wound) | Immediately | √ | |
Brucellosis (Brucella species) | (( |
√ | |
Burkholderia mallei (Glanders) and pseudomallei (Melioidosis) | Immediately | √ | |
Cancer (See chapter 246-430 WAC) | Monthly | √ | |
Chancroid | Within 3 (( |
√ | |
Chlamydia trachomatis infection | Within 3 (( |
√ | |
Cholera | Immediately | √ | |
Cryptosporidiosis | Within 3 (( |
√ | |
Cyclosporiasis | Within 3 (( |
√ | |
Diphtheria | Immediately | √ | |
Disease of suspected bioterrorism
origin (( • Anthrax • Smallpox)) |
Immediately | √ | |
(( |
|||
Domoic acid poisoning | Immediately | √ | |
E. coli – Refer to "Shiga toxin-producing E. coli" | Immediately | √ | |
Emerging condition with outbreak potential | Immediately | √ | |
Giardiasis | Within 3 (( |
√ | |
Gonorrhea | Within 3 (( |
√ | |
Granuloma inguinale | Within 3 (( |
√ | |
Gunshot wounds (nonfatal) | Monthly | √ | |
Haemophilus influenzae (invasive disease, children under age 5) | Immediately | √ | |
Hantavirus pulmonary syndrome | Within 3 (( |
√ | |
(( |
|||
Hepatitis A (acute infection) | (( |
√ | |
Hepatitis B (acute infection) | Within (( |
√ | |
Hepatitis B surface antigen + pregnant women | Within 3 (( |
√ | |
Hepatitis B (chronic infection) – Initial diagnosis, and previously unreported prevalent cases | Monthly | √ | |
Hepatitis C – Acute infection | Within 3 business days | √ | |
Hepatitis C – (( |
Monthly | √ | |
(( |
|||
Hepatitis D (acute and chronic infection) | Within 3 business days | √ | |
Hepatitis E (acute infection) | Within 24 hours | √ | |
Human immunodeficiency virus (HIV) infection | Within 3 (( |
√ | |
Influenza, novel or unsubtypable strain | Immediately | √ | |
Influenza-associated death (laboratory confirmed) | Within 3 business days | √ | |
Legionellosis | Within (( |
√ | |
Leptospirosis | Within (( |
√ | |
Listeriosis | (( |
√ | |
Lyme Disease | Within 3 (( |
√ | |
Lymphogranuloma venereum | Within 3 (( |
√ | |
Malaria | Within 3 (( |
√ | |
Measles (rubeola) – Acute disease only | Immediately | √ | |
Meningococcal disease (invasive) | Immediately | √ | |
Monkeypox | Immediately | √ | |
Mumps (acute disease only) | Within (( |
√ | |
Outbreak of suspected foodborne origin | Immediately | √ | |
Outbreak of suspected waterborne origin | Immediately | √ | |
Paralytic shellfish poisoning | Immediately | √ | |
Pertussis | (( |
√ | |
Pesticide poisoning (hospitalized, fatal, or cluster) | Immediately | √ | |
Plague | Immediately | √ | |
Poliomyelitis | Immediately | √ | |
Prion disease | Within 3 business days | √ | |
Psittacosis | Within (( |
√ | |
Q Fever | Within (( |
√ | |
Rabies (Confirmed Human or Animal) | Immediately | √ | |
Rabies (( (Suspected human rabies exposures due to a bite from or other exposure to an animal that is a local rabies reservoir species or suspected of being infected with rabies) |
(( |
√ | |
Relapsing fever (borreliosis) | (( |
√ | |
Rubella, acute disease only (including congenital rubella syndrome) | Immediately | √ | |
Salmonellosis | (( |
√ | |
SARS | Immediately | √ | |
Serious adverse reactions to immunizations | Within 3 (( |
√ | |
Shiga toxin-producing E. coli infections (enterohemorrhagic E. coli including, but not limited to, E. coli O157:H7) | Immediately | √ | |
Shigellosis | Immediately | √ | |
Smallpox | Immediately | √ | |
Syphilis | Within 3 (( |
√ | |
Tetanus | Within 3 (( |
√ | |
Trichinosis | Within 3 (( |
√ | |
Tuberculosis | Immediately | √ | |
Tularemia | (( |
√ | |
(( |
|||
Vaccinia transmission | Immediately | √ | |
Vancomycin-resistant Staphylococcus aureus (not to include vancomycin-intermediate) | Within 24 hours | √ | |
Varicella-associated death | Within 3 business days | √ | |
Vibriosis | Within (( |
√ | |
Viral hemorrhagic fever | Immediately | √ | |
Yellow fever | Immediately | √ | |
Yersiniosis | Within (( |
√ | |
Other rare diseases of public health significance | (( |
√ | |
Unexplained critical illness or death | (( |
√ |
(√) Indicates which agency should receive case and suspected case reports. |
[Statutory Authority: RCW 43.20.050, 70.24.125. 05-03-055, § 246-101-301, filed 1/11/05, effective 2/11/05. Statutory Authority: RCW 43.20.050, 43.70.545, 70.24.125, 70.28.010 and 70.104.030. 00-23-120, § 246-101-301, filed 11/22/00, effective 12/23/00.]
(((1))) (a) Notify the local health department where the
patient resides ((()), or, in the event that patient residence
cannot be determined, ((notify)) the local health department
where the health care facility is located(())), regarding:
(((a))) (i) Cases of notifiable conditions specified as
notifiable to the local health department in Table HF-1 of WAC 246-101-301 that occur or are treated in the health care
facility.
(((b))) (ii) Cases of conditions specified as notifiable
by the local health officer within that health officer's
jurisdiction that occur or are treated in the health care
facility.
(((c))) (iii) Suspected cases of notifiable conditions
for conditions that are designated immediately notifiable in
Table HF-1 of WAC 246-101-301 that occur or are treated in the
health care facility.
(((d))) (iv) Outbreaks or suspected outbreaks of disease
that occur or are treated in the health care facility((. These patterns include)) including, but ((are)) not limited
to, suspected or confirmed outbreaks of ((chickenpox))
varicella, influenza, viral meningitis, ((nosocomial)) health
care-associated infection suspected due to contaminated
products or devices, or environmentally related disease. ((Reports of outbreaks and suspected outbreaks of disease are
to be made to the local health officer.
(e))) (v) Known barriers which might impede or prevent compliance with orders for infection control or quarantine; and
(((f))) (vi) Name, address, and other pertinent
information for any case, suspected case or carrier refusing
to comply with prescribed infection control measures.
(((2))) (b) Notify the department ((of health)) of
conditions designated as notifiable to the local health
department when:
(((a))) (i) A local health department is closed or
representatives of the local health department are unavailable
at the time a case or suspected case of an immediately
notifiable condition as specified in Table HF-1 of WAC 246-101-301 occurs;
(((b))) (ii) A local health department is closed or
representatives of the local health department are unavailable
at the time an outbreak or suspected outbreak of communicable
disease occurs.
(((3))) (c) Notify the department as specified in Table
HF-1 of WAC 246-101-301 regarding cases of notifiable
conditions specified as notifiable to the department.
(((4))) (d) Notify the department of cancer incidence as
required by chapter 246-430 WAC.
(((5))) (e) Ensure that positive ((cultures and))
preliminary test results and positive final test results for
notifiable conditions of specimens referred to laboratories
outside of Washington for testing are correctly notified to
the correct local health department as specified in Table
Lab-1 of WAC 246-101-201. This requirement can be satisfied
by:
(((a))) (i) Arranging for the referral laboratory to
notify ((either)) the local health department, the department,
or both; or
(((b))) (ii) Receiving the test result from the referral
laboratory, and forwarding the notification to the local
health department, the department, or both.
(((6))) (f) Cooperate with public health authorities
during investigation of:
(((a))) (i) Circumstances of a case or suspected case of
a notifiable condition or other communicable disease; and
(((b))) (ii) An outbreak or suspected outbreak of
disease.
(((7))) (g) Provide adequate and understandable
instruction in disease control measures to each patient who
has been diagnosed with a case of a communicable disease, and
to ((contacts)) other persons who may have been exposed to the
communicable disease.
(((8))) (h) Maintain an infection control program as
described in WAC ((246-320-265)) 246-320-176 for hospitals and
WAC 246-330-176 for ambulatory surgical facilities.
(((9))) (2) Health care facilities may assume the burden
of notification for health care providers practicing within
the health care facility where more than one health care
provider is in attendance for a patient with a notifiable
condition.
(((10))) (3) Health care facilities may not assume the
burden of notification for laboratories within the health care
facility. Laboratories within a health care facility must
submit specimens to the Washington state public health
laboratories and notify public health authorities of
notifiable conditions as specified in Table Lab-1 of WAC 246-101-201.
(4) By July 1, 2011, when ordering a laboratory test for a notifiable condition, health care facilities must provide the laboratory with the following information for each test order:
(a) Patient name;
(b) Patient address including zip code;
(c) Patient date of birth;
(d) Patient sex;
(e) Name of the principal health care provider;
(f) Telephone number of the principal health care provider;
(g) Type of test requested;
(h) Type of specimen;
(i) Date of ordering specimen collection.
[Statutory Authority: RCW 43.20.050, 43.70.545 and 70.104.030. 00-23-120, § 246-101-305, filed 11/22/00, effective 12/23/00.]
(a))) Health care facilities shall adhere to the following timelines and procedures:
(1) Conditions designated as immediately notifiable must
be reported ((by telephone or by secure facsimile copy of a
written case report)) to the local health officer or the
department as specified in Table HF-1((;
(b))) immediately at the time of diagnosis or suspected diagnosis. This applies twenty-four hours a day, seven days a week. Each local health jurisdiction, as well as the department, maintains after-hours emergency phone contacts for this purpose. A party sending notification by secure facsimile copy or secure electronic transmission during normal public health business hours must confirm immediate receipt by a live person.
(2) Conditions designated as notifiable within twenty-four hours must be reported to the local health officer or the department, as specified in Table HF-1 of WAC 246-101-301, within twenty-four hours of diagnosis or suspected diagnosis, seven days a week. Reports during normal public health business hours may be sent by secure electronic transmission, telephone, or secure facsimile copy of a case report. A party sending a report outside of normal public health business hours must use the after-hours emergency telephone contact for the appropriate jurisdiction;
(3) Conditions designated as notifiable within three
((working)) business days must be reported to the local health
officer or the department as specified in Table HF-1 of WAC 246-101-301 within three business days. Notification may be
sent by written case report, secure electronic transmission,
telephone, or secure facsimile copy ((to the local health
officer or department as specified in Table HF-1)) of a case
report; and
(((c))) (4) Conditions designated as notifiable on a
monthly basis must be reported to the local health officer or
the department as specified in Table HF-1 of WAC 246-101-301
on a monthly basis. Notification may be sent by written case
report, secure electronic transmission, telephone, or secure
facsimile copy ((to the local health officer or the department
as specified in Table HF-1.
(2) The local health officer may authorize notifications by telephone or secure electronic transmission for cases and suspect cases of notifiable conditions specified as notifiable to local health departments.
(3) The state health officer may authorize notifications by telephone or secure electronic transmission for cases and suspected cases of notifiable conditions specified as notifiable to the department)) of a case report.
[Statutory Authority: RCW 43.20.050, 70.24.125, 70.28.010 and 70.104.030. 00-23-120, § 246-101-310, filed 11/22/00, effective 12/23/00.]
(a) Patient name;
(b) Patient address including zip code;
(c) Patient telephone number;
(d) Patient date of birth;
(e) Patient sex;
(f) Diagnosis or suspected diagnosis of disease or condition;
(g) Pertinent laboratory data (if available);
(h) Name ((and address or telephone number)) of the
principal health care provider;
(i) Telephone number of the principal health care provider;
(j) Address of the principal health care provider;
(k) Name and ((address or)) telephone number of the
person providing the report; and
(((j))) (l) Other information as the department may
require on forms generated by the department.
(2) The local health officer or state health officer may require other information of epidemiological or public health value.
[Statutory Authority: RCW 43.20.050, 43.70.545, 70.24.125, 70.28.010 and 70.104.030. 00-23-120, § 246-101-315, filed 11/22/00, effective 12/23/00.]
(2) Personnel in health care facilities who know of a person with a notifiable condition, other than a sexually transmitted disease, shall release identifying information only to other individuals responsible for protecting the health and well-being of the public through control of disease.
(3) Personnel in health care facilities with knowledge of a person with sexually transmitted disease, and following the basic principles of health care providers, which respect the human dignity and confidentiality of patients:
(a) May disclose the identity of a person or release identifying information only as specified in RCW 70.24.105; and
(b) Shall under RCW 70.24.105(6), use only the following customary methods for exchange of medical information:
(i) Health care providers may exchange medical information related to HIV testing, HIV test results, and confirmed HIV or confirmed STD diagnosis and treatment in order to provide health care services to the patient.
(ii) This means that information shared impacts the care or treatment decisions concerning the patient; and the health care provider requires the information for the patient's benefit.
(4) Personnel responsible for health care facility
management are authorized to permit access to medical
information as necessary to fulfill professional duties. Health care facility administrators shall advise those persons
permitted access under this section of the requirement to
maintain confidentiality of such information as defined under
this section and chapter 70.24 RCW. Professional duties means
the following activities or activities that are functionally
similar ((activities)):
(a) Medical record or chart audits;
(b) Peer reviews;
(c) Quality assurance;
(d) Utilization review purposes;
(e) Research as authorized under chapters 42.48 and 70.02 RCW;
(f) Risk management; and
(g) Reviews required under federal or state law or rules.
(5) Personnel responsible for health care facility management are authorized to permit access to a patient's medical information and medical record by medical staff or health care facility staff to carry out duties required for care and treatment of a patient and the management of medical information and the patient's medical record.
(6) Health care facilities conducting a clinical HIV research project shall report the identity of an individual participating in the project unless:
(a) The project has been approved by an institutional review board; and
(b) The project has a system in place to remind referring health care providers of their reporting obligations under this chapter.
(7) Health care facilities shall establish and implement policies and procedures to maintain confidentiality related to a patient's medical information.
[Statutory Authority: RCW 43.20.050, 43.70.545 and 70.104.030. 00-23-120, § 246-101-320, filed 11/22/00, effective 12/23/00.]
(((1))) (a) Notify the local health officer of the
jurisdiction in which the human resides of any suspected human
case or suspected human outbreak based on the human's exposure
to a confirmed animal case of any disease listed in Table
((HC-1 that is transmissible from animals to humans. Examples
of these zoonotic diseases include:
(a) Anthrax;
(b) Brucellosis;
(c) Encephalitis, viral;
(d) Plague;
(e) Rabies;
(f) Psittacosis;
(g) Tuberculosis; and
(h) Tularemia.)) V-1 of this section:
Table V-1 (Conditions Notifiable by Veterinarians)
Notifiable Condition | Time Frame for Notification | Notifiable to Local Health Department |
Anthrax | Immediately | √ |
Arboviral Disease | Within 24 hours | √ |
Brucellosis (Brucella species) | Within 24 hours | √ |
Burkholderia mallei (Glanders) | Immediately | √ |
Disease of suspected bioterrorism origin (including but not limited to anthrax) | Immediately | √ |
E. coli – Refer to "Shiga toxin-producing E. coli" | Immediately | √ |
Emerging condition with outbreak potential | Immediately | √ |
Influenza virus, novel or unsubtypable strain | Immediately | √ |
Leptospirosis | Within 24 hours | √ |
Plague | Immediately | √ |
Psittacosis | Within 24 hours | √ |
Q Fever | Within 24 hours | √ |
Rabies (suspected human or animal) | Immediately | √ |
Shiga toxin-producing E. coli infections (enterohemorrhagic E. coli including, but not limited to, E. coli O157:H7) | Immediately | √ |
Tularemia | Immediately | √ |
(√) Indicates that the condition is notifiable to the local health department. |
(((3))) (c) Cooperate with public health authorities in
the implementation of infection control measures including
isolation and quarantine.
(2) The department of agriculture is requested to inform the department of health of reported animal cases of the conditions in Table V-1 of this section. The department of health shall then notify the pertinent local health jurisdiction.
(3) The department of agriculture is requested to require submission by veterinarians of the following types of specimens or isolates and shall forward to the Washington state public health laboratories within twenty-four hours of receipt:
(a) Mycobacterium tuberculosis.
(b) Cryptococcus non v. neoformans.
(c) Vancomycin-resistant Staphylococcus aureus.
[Statutory Authority: RCW 43.20.050. 00-23-120, § 246-101-405, filed 11/22/00, effective 12/23/00.]
(1) Notify the local health department of potential foodborne disease as required in WAC 246-215-260.
(2) Cooperate with public health authorities in the
investigation of cases ((and)), suspected cases, ((or))
outbreaks, and suspected outbreaks of foodborne or waterborne
disease. This includes the release of the name and other
pertinent information about food handlers diagnosed with a
communicable disease as it relates to a foodborne or
waterborne disease investigation.
(3) Not release information about food handlers with a communicable disease to other employees or the general public.
[Statutory Authority: RCW 43.20.050. 00-23-120, § 246-101-410, filed 11/22/00, effective 12/23/00.]
(1) Notify the local health department of cases ((or)),
suspected cases, ((or)) outbreaks, and suspected outbreaks of
notifiable conditions that may be associated with the child
day care facility.
(2) Consult with a health care provider or the local health department for information about the control and prevention of infectious or communicable disease, as necessary.
(3) Cooperate with public health authorities in the
investigation of cases ((and)), suspected cases, ((or))
outbreaks, and suspected outbreaks of disease that may be
associated with the child day care facility.
(4) ((Child day care facilities shall)) Establish and
implement policies and procedures to maintain confidentiality
related to medical information in their possession.
[Statutory Authority: RCW 43.20.050. 00-23-120, § 246-101-415, filed 11/22/00, effective 12/23/00.]
(1) Notify the local health department of cases ((or)),
suspected cases, ((or)) outbreaks, and suspected outbreaks of
disease that may be associated with the school.
(2) Cooperate with the local health department in monitoring influenza.
(3) Consult with a health care provider or the local health department for information about the control and prevention of infectious or communicable disease, as necessary.
(4) Cooperate with public health authorities in the
investigation of cases ((and)), suspected cases, ((or))
outbreaks, and suspected outbreaks of disease that may be
associated with the school.
(5) ((Personnel in schools who know of a person with a
notifiable condition shall)) Release identifying information
only to other individuals responsible for protecting the
health and well-being of the public through control of
disease.
(6) Schools shall establish and implement policies and procedures to maintain confidentiality related to medical information in their possession.
[Statutory Authority: RCW 43.20.050. 00-23-120, § 246-101-420, filed 11/22/00, effective 12/23/00.]
(a) Cooperate with public health authorities in the
investigation of cases ((and)), suspected cases, ((or))
outbreaks, and suspected outbreaks of notifiable conditions or
other communicable diseases; and
(b) Cooperate with the implementation of infection control measures, including isolation and quarantine.
(2) Members of the general public may notify the local
health department of any case ((or)), suspected case, ((or))
outbreak, or potential outbreak of communicable disease.
[Statutory Authority: RCW 43.20.050. 00-23-120, § 246-101-425, filed 11/22/00, effective 12/23/00.]
(((1))) (a) Review and determine appropriate action for:
(((a))) (i) Each reported case or suspected case of a
notifiable condition;
(((b))) (ii) Any disease or condition considered a threat
to public health; and
(((c))) (iii) Each reported outbreak or suspected
outbreak of disease, requesting assistance from the department
in carrying out investigations when necessary((;)).
(((2))) (b) Establish a system at the local health
department for maintaining confidentiality of written records
and written and telephoned notifiable conditions case reports;
(((3))) (c) Notify health care providers, laboratories,
and health care facilities within the jurisdiction of the
health department of requirements in this chapter;
(((4))) (d) Notify the department of cases of any
condition notifiable to the local health department (except
animal bites) upon completion of the case investigation;
(((5))) (e) Distribute appropriate notification forms to
persons responsible for reporting;
(((6))) (f) Notify the principal health care provider, if
possible, prior to initiating a case investigation by the
local health department((.));
(((7))) (g) Carry out the HIV partner notification
requirements of WAC 246-100-072((.));
(((8))) (h) Allow laboratories to contact the health care
provider ordering the diagnostic test before initiating
patient contact if requested and the delay is unlikely to
jeopardize public health;
(((9))) (i) Conduct investigations and institute control
measures in accordance with chapter 246-100 WAC((;)).
(((10))) (2) The local health department may adopt
alternate arrangements for meeting the reporting requirements
under this chapter through cooperative agreement between the
local health department and any health care provider,
laboratory or health care facility;
(((11))) (3) Each local health officer has the authority
to:
(a) Carry out additional steps determined to be necessary to verify a diagnosis reported by a health care provider;
(b) Require any person suspected of having a ((reportable
disease or)) notifiable condition to submit to examinations
required to determine the presence of the ((disease or))
condition;
(c) Investigate any case or suspected case of a reportable disease or condition or other illness, communicable or otherwise, if deemed necessary;
(d) Require the notification of additional conditions of public health importance occurring within the jurisdiction of the local health officer.
[Statutory Authority: RCW 70.24.130 and 70.24.380. 05-11-110, § 246-101-505, filed 5/18/05, effective 6/18/05. Statutory Authority: RCW 43.20.050 (2)(d), 70.05.050 and 70.05.060. 03-06-003, § 246-101-505, filed 2/19/03, effective 2/19/03. Statutory Authority: RCW 43.20.050. 00-23-120, § 246-101-505, filed 11/22/00, effective 12/23/00.]
(1) Local health departments shall notify the department
immediately by telephone or secure electronic data
transmission of any ((notification of a)) case or suspected
case of:
(a) Botulism;
(b) Cholera;
(c) Diptheria;
(d) Disease of suspected bioterrorism origin (((examples:
Anthrax, plague, smallpox);
(d) Hemolytic uremic syndrome));
(e) Emerging condition with outbreak potential;
(f) Influenza, novel strain;
(g) Measles;
(((f))) (h) Paralytic shellfish poisoning;
(((g))) (i) Plague;
(j) Poliomyelitis; ((and
(h) Unexplained critical illness or death.))
(k) Rabies, human;
(l) SARS;
(m) Smallpox;
(n) Tularemia;
(o) Viral hemorrhagic fever; and
(p) Yellow fever.
(2) Immediate notifications of cases and suspected cases
((must)) shall include:
(a) Patient name;
(b) Patient's notifiable condition; and
(c) Condition onset date.
(3) For each case of any condition notifiable to the local health department, submit to the department case report either on a form provided by the department or in a format approved by the department. Case reports must be sent by secure electronic transmission or telephone within seven days of completing the case investigation. If the case investigation is not complete within twenty-one days of notification, pertinent information collected from the case investigation must be sent to the department and shall include:
(a) Patient name;
(b) Patient's notifiable condition or suspected condition;
(c) Source or suspected source; and
(d) Condition onset date.
(4) Local health officials will report asymptomatic HIV infection cases to the department according to a standard code developed by the department.
(5) When notified of an outbreak or suspected outbreak of illness due to an infectious agent or toxin, the local health department shall:
(a) Notify the department immediately by telephone or
secure electronic data transmission ((of any notification of
an outbreak or suspected outbreak of foodborne or waterborne
or other communicable disease)).
(((4) For outbreaks or suspected outbreaks of foodborne
or waterborne disease, notifications must)) (b) Include in the
initial notification:
(((a))) (i) Organism or suspected organism;
(((b))) (ii) Source or suspected source; and
(((c))) (iii) Number of persons affected.
(((5) Submit a written case report either on a form
provided by the department or in a format approved by the
department for each case of any condition notifiable to the
local health department, except animal bites, within seven
days of completing the case investigation. The department may
waive this requirement if telephone or secure electronic data
transmission provided pertinent information.
(6) Local health officials will report asymptomatic HIV infection cases to the department according to a standard code developed by the department.
(7) For any case not immediately notifiable to the department forward pertinent information collected on the case investigation for each case of any condition notifiable to the local health department to the department if the case investigation is not complete within twenty-one days of notification, including:
(a) Name;
(b) Condition or suspected condition;
(c) Source or suspected source; and
(d) Onset date.
(8))) (c) Within seven days of completing the outbreak
investigation, submit to the department a ((written)) report
on forms provided by the department or in a format approved by
the department ((for an outbreak of any notifiable condition
within seven days of completing the investigation)). The
department may waive this requirement if telephone or secure
electronic data transmission provided pertinent information.
[Statutory Authority: RCW 43.20.050, 70.24.125 and 70.28.010. 00-23-120, § 246-101-510, filed 11/22/00, effective 12/23/00.]
(a) To employees of the local health department, another local health department, or other official agencies needing to know for the purpose of administering public health laws and these regulations;
(b) To health care providers, specific designees of health care facilities, laboratory directors, and others for the purpose of collecting additional information about a case or suspected case as required for disease prevention and control;
(2) Local health officers shall require and maintain signed confidentiality agreements with all local health department employees with access to identifying information related to a case or suspected case of a person diagnosed with a notifiable condition. The agreements will be renewed at least annually and will include reference to criminal and civil penalties for violation of chapters 70.02 and 70.24 RCW and other administrative actions that may be taken by the local health department.
(3) Local health departments may release statistical summaries and epidemiological studies based on individual case reports if no individual is identified or identifiable.
[Statutory Authority: RCW 43.20.050. 00-23-120, § 246-101-515, filed 11/22/00, effective 12/23/00.]
(((1))) (a) Provide consultation and technical assistance
to local health departments and the department of labor and
industries investigating notifiable conditions reports upon
request.
(((2))) (b) Provide consultation and technical assistance
to health care providers, laboratories, health care
facilities, and others required to make notifications to
public health authorities of notifiable conditions upon
request.
(((3))) (c) Develop, maintain, and make available for
local health departments guidance on investigation and control
measures for notifiable communicable disease conditions.
(d) Develop and ((distribute)) make available forms for
the submission of notifiable conditions data to local health
departments, health care providers, laboratories, health care
facilities, and others required to make notifications to
public health authorities of notifiable conditions.
(((4))) (e) Maintain a twenty-four hour ((department))
telephone number for reporting notifiable conditions.
(((5))) (f) Develop routine data dissemination mechanisms
that describe and analyze notifiable conditions case
investigations and data. These may include annual and monthly
reports and other mechanisms for data dissemination as
developed by the department.
(((6))) (g) Conduct investigations and institute control
measures ((consistent with those indicated in the seventeenth
edition, 2000 of Control of Communicable Diseases Manual,
edited by James Chin, published by the American Public Health
Association (copy is available for review at the department
and at each local health department), except:
(a) When superseded by more up-to-date measures; or
(b) When other measures are more specifically related to Washington state)) as necessary.
(((7))) (h) Document the known environmental, human, and
((or)) other variables associated with a case or suspected
case of pesticide poisoning.
(((8))) (i) Report the results of the pesticide
investigation to the principal health care provider named in
the case report form and to the local health officer in whose
jurisdiction the exposure has occurred.
(((9))) (2) The department may:
(a) Negotiate alternate arrangements for meeting reporting requirements under this chapter through cooperative agreement between the department and any health care provider, laboratory, or health care facility.
(((10) The department may)) (b) Consolidate reporting for
notifiable conditions from any health care provider,
laboratory, or health care facility, and relieve that health
care provider, laboratory, or health care facility from
reporting directly to each local health department, if the
department can provide the report to the local health
department within the same time as the local health department
would have otherwise received it.
[Statutory Authority: RCW 43.20.050, 43.70.545 and 70.104.030. 00-23-120, § 246-101-605, filed 11/22/00, effective 12/23/00.]
(a) To employees of the local health department, other local health departments, or other official agencies needing to know for the purpose of administering public health laws and these regulations.
(b) To health care providers, specific designees of health care facilities, laboratory directors, and others for the purpose of collecting additional information about a case or suspected case as required for disease prevention and control.
(c) For research approved by an institutional review board as indicated under chapter 42.48 RCW. The institutional review board applies federal and state privacy laws to research requests for confidential information.
(2) ((The department shall require and maintain signed
confidentiality agreements with)) All department employees,
contractors, and others with access to identifying information
related to a case or suspected case of a person diagnosed with
a notifiable condition shall be required to sign a
confidentiality agreement. ((These)) The confidentiality
agreements ((will)) shall be renewed ((at least)) annually and
shall include reference to criminal and civil penalties for
violation of chapters 70.02 and 70.24 RCW and other
administrative actions that may be taken by the department.
[Statutory Authority: RCW 43.20.050, 43.70.545 and 70.104.030. 00-23-120, § 246-101-610, filed 11/22/00, effective 12/23/00.]
(1) Distribute periodic epidemiological summary reports and an annual review of public health issues to local health officers and local health departments.
(2) Upon execution of a data sharing agreement, make
available any data or other documentation in its possession
((for)) regarding notifiable conditions reported directly to
the department to local health officers or their designees
((upon execution of a data sharing agreement)) within two days
of a request.
(3) Periodically distribute statistical summaries and epidemiological studies based on individual case reports if no individual is identified or identifiable.
[Statutory Authority: RCW 43.20.050, 43.70.545 and 70.104.030. 00-23-120, § 246-101-615, filed 11/22/00, effective 12/23/00.]
[Statutory Authority: RCW 43.20.050. 00-23-120, § 246-101-625, filed 11/22/00, effective 12/23/00.]
[Statutory Authority: RCW 43.20.050. 00-23-120, § 246-101-701, filed 11/22/00, effective 12/23/00.]
(1) Make ((other)) data necessary to conduct case
investigations or epidemiological summaries available within
two days of a request from the department.
(2) Execute a data sharing agreement with the department prior to implementation of this chapter.
[Statutory Authority: RCW 43.20.050. 00-23-120, § 246-101-725, filed 11/22/00, effective 12/23/00.]